Analysts think NBY stock price could increase by 525%
Nov 27, 2024, 12:25 PM
-6.78%
What does NBY do
NovaBay Pharmaceuticals, based in Emeryville, California, specializes in eyecare and wound care products, including the Avenova line and hypochlorous acid solutions for various medical applications. The company went public on October 26, 2007, and employs 24 staff members.
3 analysts think NBY stock price will increase by 524.92%. The current median analyst target is $3.80 compared to a current stock price of $0.61. The lowest analysts target is $0.86 and the highest analyst target is $6.93.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.